Israeli healthcare data in real-time technology company MDClone has completed with $26 million in its Series B financing.
Led by Israel-based healthcare technology venture capital fund aMoon, the round was also joined by Lightspeed Venture Partners and OrbiMed Israel Partners.
MDClone will use the new capital to develop its existing platform and build new products and novel approaches, leveraging data across its global network.
The latest investment has boosted the company's total funding raised to date to $41 million.